Always exciting to see cell therapy for solid tumors in the spotlight! Catch this recent segment from Arizona Horizon: t.co/e8JebUqhdF

A real world analysis of our cell therapy in patients with previously treated advanced melanoma is featured at #Tandem26: ir.iovance.com/news-release...

On #WorldCancerDay, we recognize the courage and power of the voices behind every statistic. This video from Melanoma Research Foundation underscores why we are committed to advancing cancer research: www.youtube.com/watch?app=de...

2025 MRF Denver Gala Courage Award

YouTube video by Cure Melanoma

youtube.com

A real world study of our cell therapy in patients with advanced melanoma will be presented at #Tandem26 in Salt Lake City next week! View presentation details here: tandem.virtual-meeting.org/programme/pr...

Today we reported third quarter and year to date 2025 financial results, business achievements and pipeline milestones. We hosted an audio webcast at 8:30 am ET today, listen to our audio webcast here: ir.iovance.com/events/event...

We announced positive interim data for our one-time cell therapy in advanced non-small cell lung cancer: ir.iovance.com/news-release...

If you’re in Berlin for #ESMO25, visit us at Booth 3025! Analyses from our C-144-01 clinical trial for our therapy in advanced melanoma will be included in Monday’s poster session, view the poster here: www.iovance.com/scientific-p...

Scientific Publications & Presentations - Iovance Biotherapeutics

Review abstracts, posters, presentations, and other publications.

iovance.com

Four years ago today, we officially marked the opening of the Iovance Cell Therapy Center (iCTC) in Philadelphia as the first U.S. facility dedicated to manufacturing TIL cell therapies! Learn more about iCTC and cell therapy manufacturing: www.iovance.com/iovance-cell...

We're excited to share that we received our first marketing authorization outside the U.S. for our cell therapy in advanced melanoma. Learn more: ir.iovance.com/news-release...

We are honored to present the SITC Medal of Honor to Marc Theoret for his incredible partnership while at the FDA. This award recognizes his stewardship of innovative regulatory approaches to immuno-oncology drug development and approval. LEARN MORE: www.sitcancer.org/about/awards...

🫁 Lung cancer is the leading cause of cancer death worldwide. On #WorldLungCancerDay, we reaffirm our commitment to changing the way cancer is treated. 🔬 Learn about our ongoing lung cancer clinical trial: www.tilcelltherapy.com/clinical-tri... #LungCancerResearch

We're in for Chicago at #ASCO25! Visit us at Booth 14111 or check out our presentation or poster: ir.iovance.com/news-release...

Throughout the year and especially during #MelanomaAwarenessMonth, we are committed to following the science to drive innovation for patients. Check out @melanomaresearch.bsky.social's recent webinar on a clinical trial option: www.curemelanoma.org/blog/mra-mee...

MRA Meet Ups: Clinical Trials and the Current State of TIL Therapy - TILVANCE-301 - Melanoma Research Alliance

On Feb 19, MRA's Meet-Up covered TIL therapy, the TILVANCE-301 trial, and a patient-physician duo’s insights on clinical trials and the future of melanoma treatment.

curemelanoma.org

www.jsonline.com/story/news/h...

Wisconsin man first to benefit from newly approved cancer drug

Rusty Konkol's metastatic melanoma, the most dangerous form of skin cancer, is being treated at Froedtert with a newly approved cancer drug.

jsonline.com

5-yr results of our phase 2 study of lifileucel in advanced melanoma will be presented for the first time at #ASCO25. Learn more: ir.iovance.com/news-release...

Philly weekly roundup: Iovance Biotherapeutics expands; Jawnt-SpotHero partnership; Mayor’s budget address

Philly weekly roundup: Iovance Biotherapeutics expands; Jawnt-SpotHero partnership; Mayor’s budget address

Plus, Creative Mornings is launching an Indie Business Club for entrepreneurs looking for community.

technical.ly

At Iovance, we recognize and celebrate the pivotal role women play in advancing science and innovation. #womeninbiotech #womenshistorymonth #womeninSTEM

Today Iovance reported fourth quarter and full year 2024 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: ir.iovance.com/news-release...

Please join us in welcoming Dan Kirby to Iovance in the newly created role of Chief Commercial Officer: ir.iovance.com/news-release...

This Black History Month, we honor African American dermatologists who paved the way for skin health research. By supporting diverse voices in dermatology, we accelerate scientific discovery and improve outcomes for all melanoma patients. #BlackHistoryMonth #HealthEquality

Iovance is ready for an exciting 2025! We continue to expect significant growth in line with our full-year revenue guidance for 2024 and 2025. Check out our latest corporate presentation: ir.iovance.com/news-events/...

Dr. Raj Puri has been promoted to Chief Regulatory Officer at Iovance! Raj has been instrumental in our U.S. FDA approval and in advancing regulatory submissions in the EU, UK, Canada, Australia, and Switzerland. Congratulations Raj! ir.iovance.com/news-release...

Today at 12:40 pm ET, our COO Igor Bilinsky and SVP Medical Affairs Peter A. Prieto, MD will participate in a fireside chat at the Stifel 2024 Healthcare Conference. Register here for the live webcast or replay: ir.iovance.com/events/event...